AI assistant
Sending…
Equillium, Inc. — Director's Dealing 2025
May 23, 2025
34270_dirs_2025-05-23_05f739e8-430c-4b2f-b750-00732caf449d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Equillium, Inc. (EQ)
CIK: 0001746466
Period of Report: 2025-05-21
Reporting Person: DEMSKI MARTHA J (N/A)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-05-21 | Director Stock Option (right to buy) | $0.39 | A | 20000 | Acquired | 2035-05-20 | Common Stock (20000) | Direct |
Footnotes
F1: The option vests in twelve equal monthly installments commencing on the grant date of May 21, 2025, provided that the option will, in any case, be fully vested on the date of the Issuer's annual meeting of stockholders following the grant date.
More from Equillium, Inc.
Regulatory Filings
2026
May 29
Annual Report
2026
Apr 15
Proxy Solicitation & Information Statement
2026
Apr 15
Regulatory Filings
2026
Apr 7
Regulatory Filings
2026
Mar 26
Regulatory Filings
2026
Mar 25
Annual Report
2026
Mar 25
Major Shareholding Notification
2026
Mar 20
Director's Dealing
2026
Feb 23
Director's Dealing
2026
Jan 9